Oestrogen Receptor Alpha in Myocyte Maintains Muscle Regeneration in Duchenne Muscular Dystrophy
Journal of Cachexia, Sarcopenia and Muscle · 2025
DOI: 10.1002/jcsm.13807 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cachexia, Sarcopenia and Muscle, 2025. Verfasst von Xiaofei Huang und 12 weiteren Autor:innen. Beteiligte Einrichtung: New Drug Screening and Pharmacodynamics Evaluation Center, China Pharmaceutical University, Nanjing, China. Hauptthemen laut MEDLINE: Muscular Dystrophy, Duchenne, Estrogen Receptor alpha, Regeneration, Muscle, Skeletal. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, 'Double First-Class' University project, Natural Science Foundation of Jiangsu Province.
Abstract (Originalsprache)
Background
Oestrogen receptor alpha (ERα) plays an important role in maintaining mitochondrial function and regulating metabolism in skeletal muscle. However, its alterations and potential mechanisms in Duchenne muscular dystrophy (DMD) remain incompletely understood. In this study, we demonstrated the protective role of ERα in myocyte for skeletal muscle regeneration in mdx mice and explored the therapeutic effects of oestrogen receptor modulators on DMD.
Methods
DMD patients' biopsies were obtained for histological analysis to explore the expression of ERα. The phenotype of muscle was analysed by histology and molecular biology. The therapeutical effect of different oestrogen receptor modulators was examined in mdx mice treated with fulvestrant (FVT, 20 mg/kg once a week) or oestradiol (E2, 1 mg/kg per day) for 4 weeks. The protective effect of ERα was performed on mdx mice after conditional knockout of ERα in skeletal muscle (ERα mKO mdx mice). Evidence of activation of ERα/oestrogen‐related receptor alpha (ERRα)/myogenic differentiation 1 (MyoD) signalling pathway was inspected in the primary myoblasts isolated from mice, and C2C12 cells received intervention with E2/FVT/ Esr1 ‐siRNA/ Esrra overexpression plasmid.
Results
The ERα expression was increased in DMD patients' triceps ( p < 0.05) and mdx mice muscles ( p < 0.05). FVT reduced ERα levels in the mdx mice muscles ( p < 0.01) but had no significant effect on skeletal muscle regeneration on mdx mice. Compared with mdx mice, E2 reduced the levels of creatine kinase (CK) and lactic dehydrogenase (LDH) ( p < 0.001) in serum, enhanced skeletal muscle function, alleviated skeletal muscle atrophy and fibre loss and upregulated the expression of ERα in GAS ( p < 0.001) and TA ( p < 0.05). The myogenic factors such as myosin heavy chain (MyHC, p < 0.001), myogenin (MyoG, p < 0.05), MyoD ( p < 0.05) and ERRα ( p < 0.001) were increased in mdx mice GAS with E2. But E2 had no effect on ERα mKO mdx mice. The primary myoblasts and C2C12 were treated with E2 displayed an increased‐on myocyte fusion index ( p < 0.05), ERα MyoD and ERRα expressions ( p < 0.05). The myocytes' fusion index ( p < 0.05) and ERα, MyoD and ERRα expression ( p < 0.05) were decreased in si‐ Esr1 ‐transfected C2C12 cells and increased in OE‐ Esrra ‐transfected C2C12 cells.
Conclusion
We demonstrated that ERα in myocyte exerted a protective effect on skeletal muscle regeneration in DMD patients and mdx mice through the ERα‐ERRα‐MyoD pathway, which has potential implications for DMD therapy strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- New Drug Screening and Pharmacodynamics Evaluation Center, China Pharmaceutical University, Nanjing, China.
- Department of Neurology Children's, Hospital of Fudan University, Shanghai, China.
- Department of Hepatobiliary Surgery Innovative Institute of Tumor Immunity and Medicine (ITIM), Anhui Province key Laboratory of Tumor Immune Microenvironment and Immunotherapy, The First Affiliated Hospital of Anhui Me…
- Center for Drug Research and Development, Guangdong Pharmaceutical University, Guangzhou, China.
- Key Laboratory of Drug Quality Control and Pharmacovigilance, Ministry of Education, China Pharmaceutical University, Nanjing, China.
ORCID-Profile: Zhenzhou Jiang
Förderung
- National Natural Science Foundation of China
- 'Double First-Class' University project
- Natural Science Foundation of Jiangsu Province
- China Postdoctoral Science Foundation
- National Key Research and Development Program of China
- National Basic Research Program of China
Zitieren
APA
Huang, X., Li, S., Wang, H., Zhao, L., Li, X., Fan, S., Hu, W., Tong, H., Guo, G., Xu, D., Zhang, L., Jiang, Z., & Yu, Q. (2025). Oestrogen Receptor Alpha in Myocyte Maintains Muscle Regeneration in Duchenne Muscular Dystrophy. Journal of Cachexia, Sarcopenia and Muscle. https://doi.org/10.1002/jcsm.13807
Vancouver
Huang X, Li S, Wang H, Zhao L, Li X, Fan S, et al. Oestrogen Receptor Alpha in Myocyte Maintains Muscle Regeneration in Duchenne Muscular Dystrophy. Journal of Cachexia, Sarcopenia and Muscle. 2025. doi:10.1002/jcsm.13807
BibTeX
@article{Huang2025,
author = {Huang, Xiaofei and Li, Sijia and Wang, Huna and Zhao, Lei and Li, Xihua and Fan, Shusheng and Hu, Wanting and Tong, Haowei and Guo, Guangyao and Xu, Dengqiu and Zhang, Luyong and Jiang, Zhenzhou and Yu, Qinwei},
title = {Oestrogen Receptor Alpha in Myocyte Maintains Muscle Regeneration in Duchenne Muscular Dystrophy},
journal = {Journal of Cachexia, Sarcopenia and Muscle},
year = {2025},
doi = {10.1002/jcsm.13807}
}
EUVIMED